What is Denali Therapeutics Inc.'s asset turnover?

Denali Therapeutics Inc. (DNLI) reported asset turnover of 0× in Q4 2025.

What is the long-term trend for Denali Therapeutics Inc.'s asset turnover?

Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s asset turnover has grown at a -100.0% compound annual growth rate (CAGR), from 0.3× to 0×.

What does asset turnover mean?

Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Denali Therapeutics Inc. DNLI Asset turnover

Asset turnover at other companies

Eli LillyLLY

0.7×+0.1×

Regeneron PharmaceuticalsREGN

0.4×0.0×

Ultragenyx PharmaceuticalRARE

0.5×+0.1×

Viking TherapeuticsVKTX

0×—

uniQureQURE

0×0.0×

BiogenBIIB

0.3×0.0×

Other financials

Income statement

See full

Revenue-—

Operating income-$137.4M+5.6%

Net income-$128.4M+3.4%

EPS (diluted)-$0.69+11.5%

Balance sheet

See full

Cash & equivalents$390.7M+551%

Total debt$40.0M-22.3%

Total equity$926.1M-17.5%

Total assets$1.3B-0.4%

Cash flow

See full

Operating cash flow-$131.2M+0.2%

CapEx$2.5M-51.4%

Free cash flow-$133.7M+2.1%

Valuation

See full

Market cap$3.93B+54.2%

Profitability

See full

Operating margin-37,938%-37,986pp

Net margin-33,121.9%-33,159pp

FCF margin-31,736.3%-31,830pp

Returns & leverage

See full

Return on equity-49.6%+34.2pp

Debt / equity0×0.0×

Current ratio9.3×-0.3×

Where this comes from

Calculated from Denali Therapeutics Inc.’s reported figures.

total revenue/total assets=0×

Based on trailing twelve months.

The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Denali Therapeutics Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Denali Therapeutics Inc.'s asset turnover?: Denali Therapeutics Inc. (DNLI) reported asset turnover of 0× in Q4 2025.
What is the long-term trend for Denali Therapeutics Inc.'s asset turnover?: Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s asset turnover has grown at a -100.0% compound annual growth rate (CAGR), from 0.3× to 0×.
What does asset turnover mean?: Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.